Results 81 to 90 of about 10,027 (205)
Risk Factors Associated with the Severity of Thyroid-Associated Orbitopathy in Korean Patients [PDF]
, 2010 Risk Factors Associated with the Severity of Thyroid-Associated Orbitopathy in Korean ...
이상열 +5 more
core +1 more source
RNFL Study in Graves Orbitopathy
, 2010 Purpose:to determine changes of retinal nerve fiber layer (RNFL) in a group of patients with serious thyroid-related immune orbitopathy and compare it with a group of patients with moderate Graves orbitopathy.
CAMPANERUT, SARA +4 more
core
, 2013 Mild to moderate forms of orbitopathy are common in auto-immune thyroid diseases, whereas severe forms are rare. Euthyroidism restoration, no smoking, and ocular local lubricants are necessary for all the patients.
Hamédani, M., Obéric, A.
core +1 more source
Immunomodulators in Graves’ ophthalmopathy: a systematic review
Frontiers in EndocrinologyBackgroundGraves’ Ophthalmopathy (GO), or thyroid eye disease, is an extrathyroidal complication of Graves’ disease, causing a significant impact on patients’ quality of life. There are consensus statements from both the American Thyroid Association (ATA)
Antoinette Yeung +10 more
doaj +1 more source
Bangabandhu Sheikh Mujib Medical University Journal, 2016 Background: The eye changes associated with thyroid disease are referred to as Thyroid related Orbitopathy. A well described association exist between open angle glaucoma and thyroid related orbitopathy, the possible relationship between open angle ...
Saleha Sultana +3 more
doaj +1 more source
Medical Treatment of Graves’ Orbitopathy
Hormone and Metabolic Research, 2015 The medical treatment of Graves' orbitopathy (GO) is usually reserved to moderate to severe disease. Steroids have been widely employed and possess anti-inflammatory activity, but about 20-30% of patients are not responsive and about 20% present with disease recurrence.
Salvi, M., Campi, I.
openaire +2 more sources
Perspective in pharmacological management of Graves' hyperthyroidism and orbitopathy
, 2008 Drugs currently used for Graves' hyperthyroidism (thionamides) or for the major extrathyroidal expression of Graves' disease, Graves' , orbitopathy (systemic glucocorticoids with or without orbital radiotherapy), have limited effects on the autoimmune ...
Bartalena L., Tanda M. L., Lai A.
core +1 more source
Case Reports in Endocrinology, 2020 We describe a case of worsening Graves’ orbitopathy due to immune reconstitution inflammatory syndrome (IRIS) in a 38-year-old HIV-infected male after beginning ART (antiretroviral therapy).
Ravali Nallu +3 more
doaj +1 more source
The Clinical Characteristics of Thyroid Orbitopathy in Thyroid Dysfunction Patients in Korea
, 2008 PURPOSE: To investigate the clinical manifestation of thyroid orbitopathy among patients with thyroid dysfunction. METHODS: A cross-sectional study was conducted at 24 general hospitals in Korea.
이상열
core +1 more source
Sirolimus for the treatment of Graves’ orbitopathy
Thyroid ResearchA role of mTOR (mammalian target of rapamycin) in the pathogenesis of Graves' Orbitopathy (GO) has been proposed and rapamycin, better known as sirolimus, an mTOR inhibitor, was recently used in patients with GO. Here we review the available studies evaluating the role of mTOR in GO pathogenesis and the effects of sirolimus on GO.A comprehensive search
Simone Comi +4 more
openaire +5 more sources